Comparing access to orphan medicinal products in Europe

被引：0
|
作者：
Bernarda Zamora
Francois Maignen
Phill O’Neill
Jorge Mestre-Ferrandiz
Martina Garau
机构：
[1] Office of Health Economics,
来源：
Orphanet Journal of Rare Diseases | / 14卷
关键词：
Orphan drugs; Access; HTA; Reimbursement;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Comparing access to orphan medicinal products in Europe
    Zamora, Bernarda
    Maignen, Francois
    O'Neill, Phill
    Mestre-Ferrandiz, Jorge
    Garau, Martina
    ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
  • [2] Orphan medicinal products in Europe
    Héron, E
    M S-MEDECINE SCIENCES, 2005, 21 : 66 - 68
  • [3] Access to orphan medicinal products in Belgium: Quality of clinical evidence
    Dupont, A. G.
    Van Wilder, P. B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (05) : 734 - 734
  • [4] Orphan medicinal products' access to the Bulgarian pharmaceutical market - challenges and obstacles
    Kamusheva, Maria
    Tachkov, Konstantin
    Petrova, Guenka
    Savova, Alexandra
    Manova, Manoela
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (02): : 95 - 104
  • [5] Access Challenges of Advanced Therapy Medicinal Products in Europe
    Szulc, E.
    Tschumi, B.
    Pennese, N.
    Lecureuil, C.
    Robbins, S.
    VALUE IN HEALTH, 2022, 25 (12) : S336 - S336
  • [6] European incentives for orphan medicinal products
    Enzmann, H.
    Luetz, J.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2008, 51 (05) : 500 - 508
  • [7] The orphan medicinal products: an international challenge
    Meyers, A
    Di Paola, ML
    MINERVA BIOTECNOLOGICA, 2003, 15 (02) : 161 - 166
  • [8] Availability of orphan medicinal products in the EU
    Bignami, F
    le Cam, Y
    Faurisson, F
    Houyez, F
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2004, 14 (04): : 81 - 81
  • [9] Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?
    Brabers, Anne E. M.
    Moors, Ellen H. M.
    van Weely, Sonja
    de Vrueh, Remco L. A.
    ORPHANET JOURNAL OF RARE DISEASES, 2011, 6
  • [10] Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?
    Anne EM Brabers
    Ellen HM Moors
    Sonja van Weely
    Remco LA de Vrueh
    Orphanet Journal of Rare Diseases, 6
12345